Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in Elderly People Over 85 Years of Age: Real World Data From Greece

NCT04756817 is registered in ClinicalTrials.gov with G.Gennimatas General Hospital as lead sponsor.

NCT NCT04756817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04756817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in Elderly People Over 85 Years of Age: Real World Data From Greece
Lead sponsor
G.Gennimatas General Hospital
Phase
Observational
Overall status
Completed
Start date
February 13, 2021
Completion date
September 30, 2021
Enrollment
297 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunogenicity, vaccine